PT2732048T - Novo classificador para a classificação molecular de mieloma múltiplo - Google Patents

Novo classificador para a classificação molecular de mieloma múltiplo

Info

Publication number
PT2732048T
PT2732048T PT127337657T PT12733765T PT2732048T PT 2732048 T PT2732048 T PT 2732048T PT 127337657 T PT127337657 T PT 127337657T PT 12733765 T PT12733765 T PT 12733765T PT 2732048 T PT2732048 T PT 2732048T
Authority
PT
Portugal
Prior art keywords
multiple myeloma
molecular classification
new classifier
classifier
classification
Prior art date
Application number
PT127337657T
Other languages
English (en)
Inventor
Kuiper Rowan
Sonneveld Pieter
Original Assignee
Univ Erasmus Med Ct Rotterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus Med Ct Rotterdam filed Critical Univ Erasmus Med Ct Rotterdam
Publication of PT2732048T publication Critical patent/PT2732048T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT127337657T 2011-07-14 2012-07-12 Novo classificador para a classificação molecular de mieloma múltiplo PT2732048T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11173971A EP2546357A1 (en) 2011-07-14 2011-07-14 A new classifier for the molecular classification of multiple myeloma.

Publications (1)

Publication Number Publication Date
PT2732048T true PT2732048T (pt) 2017-07-18

Family

ID=46506441

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127337657T PT2732048T (pt) 2011-07-14 2012-07-12 Novo classificador para a classificação molecular de mieloma múltiplo

Country Status (18)

Country Link
US (3) US9976185B2 (pt)
EP (2) EP2546357A1 (pt)
JP (1) JP6026529B2 (pt)
KR (1) KR101933742B1 (pt)
AU (1) AU2012282437B2 (pt)
BR (1) BR112014000648B1 (pt)
CA (1) CA2841536C (pt)
CL (1) CL2014000103A1 (pt)
DK (1) DK2732048T3 (pt)
EA (1) EA032730B1 (pt)
ES (1) ES2633165T3 (pt)
IL (1) IL230164A (pt)
MX (1) MX346314B (pt)
NZ (1) NZ619896A (pt)
PL (1) PL2732048T3 (pt)
PT (1) PT2732048T (pt)
WO (1) WO2013007795A1 (pt)
ZA (1) ZA201400159B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2546357A1 (en) 2011-07-14 2013-01-16 Erasmus University Medical Center Rotterdam A new classifier for the molecular classification of multiple myeloma.
EP3414574A2 (en) * 2016-02-12 2018-12-19 Skylinedx B.V. Predicting response to immunomodulatory drugs (imids) in multiple myeloma patients
WO2018186740A1 (en) 2017-04-04 2018-10-11 Skylinedx B.V Method for identifying gene expression signatures
US10973820B2 (en) 2017-12-13 2021-04-13 Facio Intellectual Property B.V. Compounds for treatment of diseases related to DUX4 expression
US12235271B2 (en) 2018-04-28 2025-02-25 Beijing Normal University Molecular typing of multiple myeloma and application
CN110218789B (zh) * 2019-04-22 2022-10-04 曾文炳 一种用于预测多发性骨髓瘤患者总体生存率的基因探针组合物及试剂盒
TW202112368A (zh) 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合
CA3159239A1 (en) 2019-11-29 2021-06-03 Pui Leng Loke Novel compounds for treatment of diseases related to dux4 expression
WO2021105474A1 (en) 2019-11-29 2021-06-03 Facio Intellectual Property B.V. New compounds for treatment of diseases related to dux4 expression
CN120945052A (zh) * 2025-08-05 2025-11-14 中国人民解放军海军特色医学中心 评估多发性骨髓瘤预后及prmm风险的基因组合及其评估方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
JP2005512557A (ja) * 2001-11-07 2005-05-12 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ アーカンソー 遺伝子発現プロファイリングに基づく多発性骨髄腫の診断、予後、および治療標的候補の同定
US20080274911A1 (en) * 2006-11-07 2008-11-06 Burington Bart E Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereof
DK2087139T3 (en) * 2006-11-07 2017-02-13 Univ Arkansas Gene expression profiling-based identification of high-risk multiple myeloma genomic signatures
EP1964930A1 (en) * 2007-02-28 2008-09-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Molecular classifier for prognosis in multiple myeloma
US20110301055A1 (en) * 2008-12-05 2011-12-08 Nicholas James Dickens Methods for determining a prognosis in multiple myeloma
WO2010151731A1 (en) * 2009-06-26 2010-12-29 University Of Utah Research Foundation Materials and methods for the identification of drug-resistant cancers and treatment of same
EP2546357A1 (en) 2011-07-14 2013-01-16 Erasmus University Medical Center Rotterdam A new classifier for the molecular classification of multiple myeloma.

Also Published As

Publication number Publication date
US9976185B2 (en) 2018-05-22
EP2732048B1 (en) 2017-05-10
US10815532B2 (en) 2020-10-27
AU2012282437A1 (en) 2014-01-23
NZ619896A (en) 2016-04-29
MX2014000440A (es) 2014-07-09
DK2732048T3 (en) 2017-08-07
BR112014000648B1 (pt) 2020-04-07
CL2014000103A1 (es) 2014-07-04
US20180237866A1 (en) 2018-08-23
IL230164A (en) 2017-12-31
EP2546357A1 (en) 2013-01-16
ES2633165T3 (es) 2017-09-19
JP2014520540A (ja) 2014-08-25
US20210010091A1 (en) 2021-01-14
MX346314B (es) 2017-03-15
WO2013007795A1 (en) 2013-01-17
CA2841536A1 (en) 2013-01-17
ZA201400159B (en) 2017-09-27
BR112014000648A2 (pt) 2017-02-14
EP2732048A1 (en) 2014-05-21
JP6026529B2 (ja) 2016-11-16
AU2012282437B2 (en) 2016-04-21
EA032730B1 (ru) 2019-07-31
KR101933742B1 (ko) 2018-12-28
US20140221313A1 (en) 2014-08-07
KR20140044364A (ko) 2014-04-14
PL2732048T3 (pl) 2017-10-31
EA201400131A1 (ru) 2014-04-30
CA2841536C (en) 2020-09-22

Similar Documents

Publication Publication Date Title
EP2673867A2 (de) Sorter
ZA201400159B (en) A new classifier for the molecular classification of multiple myeloma
ZA201309220B (en) Micelle-coated crystalline particles
PL3699251T3 (pl) Zamknięcia wolne od pcw
GB2493836B (en) Tamper-evident label
ZA201306229B (en) Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines
EP2695045A4 (en) CLASSIFICATION OF GRAPHIC OBJECTS
GB201109804D0 (en) Product
ZA201304686B (en) Product
GB201117421D0 (en) Product
GB201110702D0 (en) Product
GB201117425D0 (en) Product
ZA201307950B (en) Product
GB201110705D0 (en) Product
GB201101996D0 (en) The stack bottle
GB201121722D0 (en) Product
GB2494900B (en) Tamper-evident packaging
GB201112016D0 (en) Closures
IL216476A0 (en) Domain-specific feature selection for clustering
GB201104862D0 (en) Sorted
GB201113960D0 (en) Tamper-evident label
AU341919S (en) Bin
ZA201205147B (en) Recycling bin
GB201114023D0 (en) resealable can
GB201114191D0 (en) Product